USFDA completes inspection at Divi’s Laboratories’ Unit-II facility in Andhra Pradesh

01 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Divi’s Laboratories’ Unit-II, Village Chippada, Bheemunipatnam District in the state of Andhra Pradesh. The inspection was conducted from January 27 to 31, 2020. The inspection has been concluded with no ‘483’ observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×